EC Number | Application | Comment | Organism |
---|---|---|---|
1.4.3.4 | medicine | ethiology of schizophrenia and affective disorders e.g. Parkinson's disease and epilepsy | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.4.3.4 | Clorgyline | - |
Homo sapiens | |
1.4.3.4 | Deprenyl | - |
Homo sapiens | |
1.4.3.4 | Pargyline | - |
Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.4.3.4 | additional information | - |
additional information | - |
Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.4.3.4 | RCH2NH2 + H2O + O2 | Homo sapiens | - |
RCHO + NH3 + H2O2 | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.4.3.4 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.4.3.4 | blood | predominantly B form | Homo sapiens | - |
1.4.3.4 | granulocyte | predominantly B form | Homo sapiens | - |
1.4.3.4 | lymphocyte | predominantly B form | Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.4.3.4 | 2-phenylethylamine + H2O + O2 | - |
Homo sapiens | 2-phenylethanal + NH3 + H2O2 | - |
? | |
1.4.3.4 | benzylamine + H2O + O2 | - |
Homo sapiens | benzaldehyde + NH3 + H2O2 | - |
? | |
1.4.3.4 | RCH2NH2 + H2O + O2 | - |
Homo sapiens | RCHO + NH3 + H2O2 | - |
? | |
1.4.3.4 | RCH2NH2 + H2O + O2 | 5-hydroxytryptamine, MAO-A selective substrate | Homo sapiens | RCHO + NH3 + H2O2 | - |
? | |
1.4.3.4 | tyramine + H2O + O2 | - |
Homo sapiens | (4-hydroxyphenyl)acetaldehyde + NH3 + H2O2 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.4.3.4 | More | isoforms differ in inhibitor sensitivity | Homo sapiens |